Home › Companies › VERVE THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and VERVE THERAPEUTICS INC.’s Form 8-K, filed 2025-06-10 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2023-2024 2024-2025
Explore VERVE THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are VERVE THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-10 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Lonnel Coats | 58,699,561 | -- | -- | 686,894 | 13,681,266 | Majority: yes |
| Elect Director: Jodie Morrison | 58,628,402 | -- | -- | 758,053 | 13,681,266 | Majority: yes |
| Elect Director: Krishna Yeshwant, M.D. | 50,208,438 | -- | -- | 9,178,017 | 13,681,266 | Majority: yes |
| Proposal 2 - Ratification of Appointment of the Company's Independent Registered Public Accounting Firm The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting | 72,754,346 | 75,512 | 237,863 | -- | 0 | Majority: yes |
| Proposal 3 - Approval, on an Advisory Basis, of Compensation Paid to Company's Named Executive Officers The stockholders of the Company approved, on an advisory basis, the compensation paid to its named executive officers. | 56,159,136 | 2,748,937 | 478,381 | -- | 13,681,266 | Majority: yes |
Source: VERVE THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-06-10 — read the filing on EDGAR.
Each item below shows how the 195 asset managers that disclosed a VERVE THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of VERVE THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 8 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
VERVE THERAPEUTICS INC.’s own tally for this item (“Proposal 3 - Approval, on an Advisory Basis, of Compensation Paid to Company's Named Executive Officers The stockholders of the Company approved, on an advisory basis, the compensation paid to its named executive officer”): 56,159,136 for, 2,748,937 against, per its Form 8-K filed 2025-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 192 asset managers below cast 95% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GV Management Company, L.L.C. | 12,168,489 | 0 | 0 | 0 | For |
| BVF INC/IL | 6,904,050 | 0 | 0 | 0 | For |
| BlackRock | 5,696,069 | 18,318 | 0 | 0 | For |
| Vanguard | 4,016,905 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,607,072 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 3,170,000 | 0 | 0 | 0 | For |
| Woodline Partners LP | 2,755,088 | 0 | 0 | 0 | For |
| State Street | 2,709,114 | 537 | 0 | 0 | For |
| ARCH Venture Management, LLC | 2,008,923 | 0 | 0 | 0 | For |
| Casdin Capital, LLC | 1,738,237 | 0 | 0 | 0 | For |
| Fidelity | 1,699,840 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,490,175 | 0 | 0 | 0 | For |
| Nuveen | 1,250,709 | 0 | 0 | 0 | For |
| TIAA | 1,220,428 | 0 | 0 | 0 | For |
| Charles Schwab | 1,142,722 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 0 | 764,793 | 0 | 0 | Against |
| Palo Alto Investors LP | 0 | 0 | 0 | 0 | 0 |
| Northern Trust | 468,693 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 440,466 | 0 | 0 | 0 | For |
| Point72 | 424,345 | 0 | 0 | 0 | For |
| American Century | 0 | 320,506 | 0 | 0 | Against |
| Two Sigma | 306,660 | 0 | 0 | 0 | For |
| JPMorgan | 298,551 | 0 | 0 | 0 | For |
| Goldman Sachs | 278,121 | 0 | 0 | 0 | For |
| SEI | 0 | 271,718 | 0 | 0 | Against |
Showing the 25 largest of 192 asset managers. See all 192 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
VERVE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Jodie Morrison”): 58,628,402 for, 758,053 withheld, per its Form 8-K filed 2025-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 52 asset managers below cast 100% of the shares they voted on this item FOR (14,093,115 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,862,068 | 0 | 0 | 0 | For |
| BlackRock | 3,493,992 | 0 | 0 | 0 | For |
| Fidelity | 1,421,709 | 0 | 0 | 0 | For |
| TIAA | 1,220,428 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,180,297 | 0 | 0 | 0 | For |
| State Street | 655,489 | 0 | 0 | 0 | For |
| Charles Schwab | 571,361 | 0 | 0 | 0 | For |
| Goldman Sachs | 221,032 | 0 | 0 | 0 | For |
| Equitable | 125,169 | 0 | 67,300 | 0 | For |
| American Century | 160,000 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 146,507 | 0 | Abstain |
| Global X | 118,874 | 0 | 0 | 0 | For |
| SEI | 111,740 | 0 | 0 | 0 | For |
| Nationwide | 93,625 | 0 | 0 | 0 | For |
| Lincoln Financial | 86,632 | 0 | 1,676 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 87,383 | 0 | 0 | 0 | For |
| Northwestern Mutual | 82,809 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 65,164 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 48,022 | 0 | 0 | 0 | For |
| John Hancock | 43,529 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 43,283 | 0 | 0 | 0 | For |
| ProShares | 37,893 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 36,757 | 0 | 0 | 0 | For |
| Pacific Life | 36,026 | 0 | 0 | 0 | For |
| Brighthouse | 23,979 | 0 | 11,841 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 3 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
VERVE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Krishna Yeshwant, M.D.”): 50,208,438 for, 9,178,017 withheld, per its Form 8-K filed 2025-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 52 asset managers below cast 100% of the shares they voted on this item FOR (9,951,675 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,862,068 | 0 | 0 | 0 | For |
| BlackRock | 471,284 | 0 | 3,022,708 | 0 | Abstain |
| Fidelity | 1,394,472 | 0 | 27,237 | 0 | For |
| TIAA | 1,220,428 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,180,297 | 0 | 0 | 0 | For |
| State Street | 654,838 | 0 | 651 | 0 | For |
| Charles Schwab | 571,361 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 221,032 | 0 | Abstain |
| Equitable | 0 | 0 | 192,469 | 0 | Abstain |
| American Century | 0 | 0 | 160,000 | 0 | Abstain |
| Dimensional | 0 | 0 | 146,507 | 0 | Abstain |
| Global X | 118,874 | 0 | 0 | 0 | For |
| SEI | 111,740 | 0 | 0 | 0 | For |
| Nationwide | 3,809 | 0 | 89,816 | 0 | Abstain |
| Lincoln Financial | 52,700 | 0 | 35,608 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 87,383 | 0 | Abstain |
| Northwestern Mutual | 82,809 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 65,164 | 0 | Abstain |
| SEI Exchange Traded Funds | 48,022 | 0 | 0 | 0 | For |
| John Hancock | 17,499 | 0 | 26,030 | 0 | Abstain |
| Columbia Threadneedle | 43,283 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 37,893 | 0 | Abstain |
| MASTER INVESTMENT PORTFOLIO | 36,757 | 0 | 0 | 0 | For |
| Pacific Life | 0 | 0 | 36,026 | 0 | Abstain |
| Brighthouse | 0 | 0 | 35,820 | 0 | Abstain |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
VERVE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Lonnel Coats”): 58,699,561 for, 686,894 withheld, per its Form 8-K filed 2025-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 52 asset managers below cast 100% of the shares they voted on this item FOR (14,093,633 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,862,068 | 0 | 0 | 0 | For |
| BlackRock | 3,493,992 | 0 | 0 | 0 | For |
| Fidelity | 1,421,709 | 0 | 0 | 0 | For |
| TIAA | 1,220,428 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,180,297 | 0 | 0 | 0 | For |
| State Street | 655,489 | 0 | 0 | 0 | For |
| Charles Schwab | 571,361 | 0 | 0 | 0 | For |
| Goldman Sachs | 221,032 | 0 | 0 | 0 | For |
| Equitable | 125,169 | 0 | 67,300 | 0 | For |
| American Century | 160,000 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 146,507 | 0 | Abstain |
| Global X | 118,874 | 0 | 0 | 0 | For |
| SEI | 111,740 | 0 | 0 | 0 | For |
| Nationwide | 93,625 | 0 | 0 | 0 | For |
| Lincoln Financial | 86,632 | 0 | 1,676 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 87,383 | 0 | 0 | 0 | For |
| Northwestern Mutual | 82,809 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 65,164 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 48,022 | 0 | 0 | 0 | For |
| John Hancock | 43,529 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 43,283 | 0 | 0 | 0 | For |
| ProShares | 37,893 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 36,757 | 0 | 0 | 0 | For |
| Pacific Life | 36,026 | 0 | 0 | 0 | For |
| Brighthouse | 23,979 | 0 | 11,841 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
VERVE THERAPEUTICS INC.’s own tally for this item (“Proposal 2 - Ratification of Appointment of the Company's Independent Registered Public Accounting Firm The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registere”): 72,754,346 for, 75,512 against, per its Form 8-K filed 2025-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 52 asset managers below cast 100% of the shares they voted on this item FOR (14,322,352 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,862,068 | 0 | 0 | 0 | For |
| BlackRock | 3,493,992 | 0 | 0 | 0 | For |
| Fidelity | 1,421,709 | 0 | 0 | 0 | For |
| TIAA | 1,220,428 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,180,297 | 0 | 0 | 0 | For |
| State Street | 655,489 | 0 | 0 | 0 | For |
| Charles Schwab | 571,361 | 0 | 0 | 0 | For |
| Goldman Sachs | 221,032 | 0 | 0 | 0 | For |
| Equitable | 192,469 | 0 | 0 | 0 | For |
| American Century | 160,000 | 0 | 0 | 0 | For |
| Dimensional | 146,507 | 0 | 0 | 0 | For |
| Global X | 118,874 | 0 | 0 | 0 | For |
| SEI | 111,740 | 0 | 0 | 0 | For |
| Nationwide | 93,625 | 0 | 0 | 0 | For |
| Lincoln Financial | 88,308 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 87,383 | 0 | 0 | 0 | For |
| Northwestern Mutual | 82,809 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 65,164 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 48,022 | 0 | 0 | 0 | For |
| John Hancock | 43,529 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 43,283 | 0 | 0 | 0 | For |
| ProShares | 37,893 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 36,757 | 0 | 0 | 0 | For |
| Pacific Life | 36,026 | 0 | 0 | 0 | For |
| Brighthouse | 23,979 | 0 | 11,841 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
95% Majority: yes · of votes cast
VERVE THERAPEUTICS INC.’s own tally for this item (“Proposal 3 - Approval, on an Advisory Basis, of Compensation Paid to Company's Named Executive Officers The stockholders of the Company approved, on an advisory basis, the compensation paid to its named executive officer”): 56,159,136 for, 2,748,937 against, per its Form 8-K filed 2025-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 200 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 0 | 200 | 0 | 0 | Against |
| Ikarian Capital, LLC | 0 | 0 | 0 | 0 | -- |
Ranked by the number of VERVE THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting.
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | GV Management Company, L.L.C. | 12,168,489 |
| 2 | BVF INC/IL | 6,904,050 |
| 3 | BlackRock | 5,714,387 |
| 4 | Vanguard | 4,016,905 |
| 5 | T. Rowe Price | 3,607,072 |
| 6 | Novo Holdings A/S | 3,170,000 |
| 7 | Woodline Partners LP | 2,755,088 |
| 8 | State Street | 2,709,651 |
| 9 | ARCH Venture Management, LLC | 2,008,923 |
| 10 | Casdin Capital, LLC | 1,738,237 |
Shown as share counts, not percentages: no shares-outstanding figure has been matched to VERVE THERAPEUTICS INC. for the 2024-2025 season, so there is no denominator to divide by.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At VERVE THERAPEUTICS INC.'s shareholder meeting held 2025-06-05, in the 2024-2025 proxy season, 195 asset managers reported how they voted in their SEC Form N-PX filings, covering 997 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS. — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: VERVE THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-10.
VERVE THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page).